A review of platelet derived growth factor playing pivotal role in bone regeneration

Journal of Oral Implantology

Volumn 40, Issue 3, 2014, Pages 330-340

  Shah, Prasun ^a   Keppler, Louise ^b   Rutkowski, James ^c  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b St Vincent Charity Hospital   (United States)

^c Clarion Research Group   (United States)

Author keywords

Bone grafting; Bone regeneration; PDGF; PDGF receptors

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANGIOGENESIS; BONE REGENERATION; BONE TRANSPLANTATION; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MACROPHAGE ACTIVATION; METHODOLOGY; MITOSIS; OSTEOSARCOMA; PDGF RECEPTORS; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

BONE GRAFTING; BONE REGENERATION; PDGF; PDGF RECEPTORS;

BONE REGENERATION; BONE TRANSPLANTATION; HUMANS; MACROPHAGE ACTIVATION; MITOSIS; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOSARCOMA; PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84903604786     PISSN: 01606972     EISSN: 15481336     Source Type: Journal    
DOI: 10.1563/AAID-JOI-D-11-00173     Document Type: Review

References (97)

1. Canalis E, McCarthy T, Centrella M. Growth factors and the regulation of bone remodeling J Clin Invest. 1988;81:277-281.
2. Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M. Growth factors in bone matrix. J Biol Chem. 1986. 261:12665-12674.
3. Heldin CH, Johnsson A, Wennergren S, Wernstedt C, Betsholtz C, Westermark B. A human osteosarcoma cell line secretes a growth factor structurally related to a homodimer of PDGF A-chains. Nature (Lond.). 1986;319:511-514.
4. Weiss HJ, Witte LD, Kaplan KL, et al. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin and platelet-derived growth factor. Blood. 1979;54:1296-1319.
5. Witte LD, Kaplan KL, Nossel HL, Lages BA, Weiss HJ, Goodman DS. Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res. 1978;42:402-409.
6. Deuel TF, Huang JS. Platelet-derived growth factor: structure, function, and roles in normal and transformed cells. J Clin Invest. 1984;74:669-676.
7. Ross R, Vogel A. The platelet derived growth factor. Cell. 1978;14:203-210.
8. Scher CD, Shepard RC, Antoniades HN, Stiles CD. Platelet-derived growth factor and the regulation of the mammalian fibroblast cell cycle. Biochim Biophys Acta. 1979;560:217-241.
9. Moore DC, Ehrlich MG, McAllister SC, et al. Recombinant human platelet-derived growth factor-BB augmentation of new bone formation in a rat model of distraction osteogenesis. J Bone Joint Surg Am. 2009; 91:1973-1984.
10. Haniu M, Hsieh P, Rohde MF, Kenney WC. Characterization of disulfide linkages in platelet-derived growth factor AA. Arch Biochem Biophys. 1994;310:433-439.
11. Haniu M, Rohde MF, Kenney WC. Disulfide bonds in recombinant human platelet-derived growth factor BB dimer: characterization of intermolecular and intramolecular disulfide linkages. Biochemistry. 1993;32:2431-2437.
12. Andersson M, Ostman A, Hellman GU, George-Nascimento C, Westermark B, Heldin CH. Assignment of inter chain disulfide bonds in platelet-derived growth factor (PDGF) and evidence for agonist activity of monomeric PDGF. J Biol Chem. 1992;267:11260-11266.
13. Kenney WC, Haniu M, Herman AC, et al. Formation of mitogenically active PDGF-B dimer does not require interchain disulfide bonds. J Biol Chem. 1994;269:12351-12359.
14. Deuel TF, Huang JS, Proffitt RT, Chang D, Kennedy BB. Human platelet-derived growth factor. Purification and resolution into two active protein fractions. J Cell Biochem. 1981;256:8896-8899.
15. Hollinger JO, Hart CE, Hirsch SN, Lynch S, Friedlaender GE. Recombinant human platelet derived growth factor: biology and clinical application. J Bone Joint Surg Am. 2008;90:48-54.
16. Huang JS, Huang SS, Deuel TF. Human platelet-derived growth factor: radioimmunoassay and discovery of a specific plasma-binding protein. Cell Biol. 1983;97:383-388.
17. Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc. 2006;81:1241-1257.
18. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet derived growth factor. Physiol Rev. 1999;79:1283-1316.
19. Gruber R, Karreth F, Frommlet F, Fischer MB, Watzek G. Platelets are mitogenic for periosteum-derived cells. J Orthop Res. 2003;21:941-948.
20. Fiedler J, Etzel N, Brenner RE. To go or not to go: migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF. J Cell Biochem. 2004;93:990-998.
21. Matsui TM, Heidaran, Miki T, Toru M, Popescu N, Rochelle LA, et al. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science. 1989;243:800-803.
22. Yeh J, Osathanondh R. Expression of messenger ribonu-cleic acids encoding for basic fibroblast growth factor (FGF) and alternatively spliced FGF receptor in human fetal ovary and uterus. J Clin Endocrinol Metab. 1993;77:1367-1371.
23. Heldin CH, Westermarck B. Mechanism of action and in-vivo role of platelet derived growth factor. Physiol Rev. 1999;79: 1284-1301.
24. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 1995;267:2003-2006.
25. Yu JC, Mahadevan D, Larochelle WJ, Pierce JH, Heidaran MA. Structural coincidence of a-PDGFR epitopes binding to platelet-derived growth factor-AA and a potent neutralizing monoclonal antibody. J Biol Chem. 1994;269:10668-10674.
26. Lokker NA, O'Hare JP, Barsoumian A, et al. Functional importance of platelet-derived growth factor (PDGF) receptor extracellular immunoglobulin-like domains. Identification of PDGF binding site and neutralizing monoclonal antibodies. J Biol Chem. 1997;272:33037-33044.
27. Omura T, Heldin CH, Ostman AO. Immunoglobulin-like domain 4-mediated receptor-receptor interactions contribute to platelet-derived growth factor-induced receptor dimerization. J Biol Chem. 1997;272:12676-12682.
28. Shulman T, Sauer FG, Jackman RM, Chang CN, Landolfi NF. An antibody reactive with domain 4 of the platelet-derived growth factor b receptor allows BB binding while inhibiting proliferation by impairing receptor dimerization. J Biol Chem. 1997;272:17400-17404.
29. Bonner JC, Osornio-Vargas AR. Differential binding and regulation of platelet-derived growth factor A and B chain isoforms by alpha 2-macroglobulin. J Biol Chem. 1995;270:16236-16242.
30. Fischer WH, Schubert D. Characterization of a novel platelet-derived growth factor-associated protein. J Neurochem. 1996;66:2213-22136.
31. Tiesman J, Hart CE. Identification of a soluble receptor for platelet-derived growth factor in cell-conditioned medium and human plasma. J Biol Chem. 1993;268:9621-9628.
32. Andersson MA, Ostman J, Kreysing GM, Van de Poll M, Heldin CH. Involvement of loop 2 of platelet-derived growth factor AA and BB in receptor binding. Growth Factors. 1995;12:159-164.
33. Larochelle WJ, Pierce JH, May-Siroff M, Giese N, Aaronson SA. Five PDGF B amino acid substitutions convert PDGF A to a PDGF B-like transforming molecule. J Biol Chem. 1992;267:17074-17077.
34. Ostman OA, Andersson M, Bäckström GM, Heldin CH. Assignment of intrachain disulfide bonds in platelet-derived growth factor B-chain. J Biol Chem. 1993;268:13372-13377.
35. Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science. 1997;278:2075-2080.
36. Heldin CH, Ostman AO, Rönnstrand L. Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta. 1998;1378:79-113.
37. Hawkins PT, Eguinoa RG, Stokoe FT, et al. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr Biol. 1995;5:393-403.
38. Hooshmand-Rad R, Claesson-Welsh L, Wennström S, Yokote K, Siegbahn A, Heldin CH. Involvement of phosphatidyli-nositide 3#sup#0#/sup#-kinase and Rac in platelet-derived growth factor-induced actin reorganization and chemotaxis. Exp Cell Res. 1997; 234:434-441.
39. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert CP, Coffer P, Downward CJ, Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 1997; 385:544-548.
40. Berridge MJ. Inositol trisphosphate and calcium signaling. Nature. 1993;361:315-325.
41. Meisenhelder J, Suh PG, Rhee SG, Hunter T. Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein tyrosine kinases in vivo and in vitro. Cell. 1989;57:1109-1122.
42. Kamat A, Carpenter G. Phospholipase C-gamma1: regulation of enzyme function and role in growth factor-dependent signal transduction. Cytokine Growth Factor Rev. 1997;8:109-117.
43. Erpel T, Courtneidge SA. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol. 1995; 7:176-182.
44. Hooshmand RA, Yokote RK, Heldin CH, Claesson WL. PDGF alpha-receptor mediated cellular responses are not dependent on Src family kinases in endothelial cells. J Cell Sci. 1998;111:607-614.
45. Schlessinger J. How receptor tyrosine kinases activate Ras. Trends Biochem Sci. 1993;18:273-275.
46. Hu QA, Klippel AJ, Muslin WJ, Fantl WJ, Williams LT. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science. 1995;268:100-102.
47. Rodriguez-Viciana, Warne PP, Dhand R, Vanhaesebroeck B, Gout I, Waterfield MD. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 1994;370:527-532.
48. Pluskey ST, Wandless J, Walsh CT, Shoelson SE. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J Biol Chem. 1995;270:2897-2900.
49. Li WR, Nishimura A, Kashishian AG, et al. A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase. Mol Cell Biol. 1994;14:509-517.
50. Heidaran MA, Beeler JF, Yu JC, et al. Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. J Biol Chem. 1993;268:9287-9295.
51. Vander G, Henkemeyer PM, Jacks T, Pawson T. Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap. Mol Cell Biol. 1997;17:1840-1847.
52. Patel BK. Wang RL, Lee CC, Taylor WG, Pierce JH, LaRochelle WJ. Stat6 and Jak1 are common elements in platelet-derived growth factor and interleukin-4 signal transduction pathways in NIH 3T3 fibroblasts. J Biol Chem. 1996;271:22175-22182.
53. Valgeirsdo TT, Paukku SK, Silvennoinen O, Heldin CH, Claesson-WL. Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains. Oncogene. 1998;16:505-515.
54. Stein DJ, Wu J, Fuqua SA, et al. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J. 1994;13:1331-1340.
55. Rozakis-Adcock M, McGlade J, Mbamalu G, et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 1992;360:689-692.
56. Porfiri E, McCormick F. Regulation of epidermal growth factor receptor signaling by phosphorylation of the Ras exchange factor hSOS1. J Biol Chem. 1996;271:5871-5877.
57. Graves LM, Bornfeldt KE, Sidhu JS, Argast GM, Raines EW, Ross R, et al. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem. 1996; 271:505-511.
58. Dahlfors GY, Chen M, Wasteson M, Arnqvist HJ. PDGF-BB-induced DNA synthesis is delayed by angiotensin II in vascular smooth muscle cells. Am J Physiol. 1998;274:H1742-1748.
59. Berti A, Rigacci S, Raugei G, Degl'Innocenti D, Ramponi G. Inhibition of cellular response to platelet-derived growth factor by low M(r) phosphotyrosine protein phosphatase overexpression. FEBS Lett. 1994;349:7-12.
60. Mooney RA, Freund GG, Way BA, Bordwell KL. Expression of a transmembrane phosphotyrosine phosphatase inhibits cellular response to platelet-derived growth factor and insulin-like growth factor-1. J Biol Chem. 1992;267:23443-23446.
61. Assoian RK. Anchorage-dependent cell cycle progression. J Cell Biol. 1997;136:1-4.
62. Koyama HE, Raines W, Bornfeldt KE, Roberts JM, Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 1996;87:1069-1078.
63. Sundberg C, Rubin K. Stimulation of beta1 integrins on fibroblasts induces PDGF independent tyrosine phosphorylation of PDGF beta-receptors. J Cell Biol. 1996;132:741-752.
64. Kirchberg KT, Lange S, Klein EC, et al. Induction of beta 1 integrin synthesis by recombinant platelet-derived growth factor (PDGF-AB) correlates with an enhanced migratory response of human dermal fibroblasts to various extracellular matrix proteins. Exp Cell Res. 1995;220:29-35.
65. Xu J, Clark AF. Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol. 1996;132:239-249.
66. Martinet Y, Bitterman PB, Mornex JF, Grotendorst GR, Martin GR, Crystal RG. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature. 1986;319:158-160.
67. Grotendorst GR, Pencev D, Martin GR, Sodek J. Molecular mediators of tissue repair. In: Hunt TK, Heppenstall RB, Pines E, Rovee D, eds. Soft and hard tissue repair. New York: Praeger, NY; 1984;20-40.
68. Grotendorst GR, Martin GR, Pencev D, Sodek J, Harvey AK. Stimulation in granulation tissue formation by platelet-derived growth factor in normal diabetic rats. J Clin Invest. 1985;76:2323-2329.
69. Howes R, Bowness J, Grotendorst G, Martin G, Reddi A. Platelet-derived growth factor enhances demineralized bone matrix-induced cartilage and bone formation. Calcif Tissue Int. 1988;42:34-38.
70. Antonaides HN, Williams LT. Human platelet-derived growth factor: structure and functions. Fed Proc. 1983;42:2630-2634.
71. Robert EM, Eric RC, Ralph ME, Steven RS, James S. Platelet rich plasma: growth enhancement factor for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638-646.
72. Bowen-Pope DF, Vogel A, Ross R. Production of platelet-derived growth factor-like molecules reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci U S A. 1984; 81:2396-2400.
73. Pierce GF, Tarpley J, Yanagihara D, Deuel TF. Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing: neovessel and matrix formation and cessation of repair. Am J Pathol. 1992;140:1375-1388.
74. Knighton D, Silver I, Hunt TK. Regulation of wound healing angiogenesis: effect of oxygen gradients and inspired oxygen concentration. Surgery. 1981;90:262-270.
75. Knighton DR, Oredsson S, Banda M, Hunt TK. Regulation of repair: hypoxic control of macrophage mediated angiogenesis. In: Hunt TK, Heppenstahl RB, Pines E, eds. Soft and hard tissue repair. New York: Praeger;1984:41-90.
76. Canalis E, McCarthy T, Centrella M. Effects of platelet-derived growth factor on bone formation in vitro. J Cell Physiol. 1989;140:530-537.
77. Gilardetti RS, Chaibi MS, Stroumza J, et al. High affinity binding of PDGF-AA and PDGF-BB to normal human osteoblastic cells and modulation by interleukin-1. Am J Physiol. 1991;C980-C985.
78. Hu Z, Peel SA, Ho SK, Sándor GK, Clokie CM. Platelet-rich plasma induces mRNA expression of VEGF and PDGF in rat bone marrow stromal cell differentiation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:43-48.
79. Bostro MH, Willetts K, Pekny M, et al. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell. 1996;85:863-873.
80. Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development. 1997;24:2691-2700.
81. Leve EN, Pekny PM, Gebre MS, Swolin B, Larsson E, Betsholtz C. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 1994;8:1875-1887.
82. Soriano P. Abnormal kidney development and hematolog-ical disorders in PDGF beta-receptor mutant mice. Genes Dev. 1994; 8:1888-1896.
83. Sasahara AJ, Kott N, Sasahara M, Raines EW, Ross R, and Westrum LE. Platelet-derived growth factor B-chain-like immuno-reactivity in the developing and adult rat brain. Dev Brain Res. 1992; 68:41-53.
84. Edelberg JM, Aird WC, Rayburn H, Mamuya WS, Mercola M, Rosenberg RD. PDGF mediates cardiac microvascular communication. J Clin Invest. 1998;102:837-843.
85. Martins RN, Chleboun JO, Sellers P, Sleigh M, Muir J. The role of PDGF-BB on the development of the collateral circulation after acute arterial occlusion. Growth Factors. 1994;10: 299-306.
86. Lindahl PB, Johansson R, Leve EP, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science. 1997;277:242-245.
87. Bryckaert MC, Rendu F, Tobelem G, Wasteson A. Collagen-induced binding to human platelets of platelet-derived growth factor leading to inhibition of P43 and P20 phosphorylation. J Biol Chem. 1989;264:4336-4341.
88. Yang ML, Khachigian M, Hicks C, Chesterman CN, Chong BH. Identification of PDGF receptors on human megakaryocytes and megakaryocytic cell lines. Thromb Hemostasis. 1997;78:892-896.
89. Vassbotn FS, Havnen OK, Heldin CH, Holmsen H. Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha-receptor. J Biol Chem. 1994;269:13874-13879.
90. Clark RA, Folkvord FJ, Hart CE, Murray MJ, McPherson JM. Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. J Clin Invest.1989; 84: 1036-1040.
91. Shimokado KE, Raines W, Madtes DK, Barrett TB, Benditt EP, Ross R. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell. 1985;43:277-286.
92. Ansel JC, Tiesman JP, Olerud JE, et al. Human keratinocytes are a major source of cutaneous platelet-derived growth factor. J Clin Invest. 1993;92:671-678.
93. Pierce GF, Tarpley JE, Tseng J, et al. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest. 1995;96:1336-1350.
94. Pierce GF, Mustoe TA, Ingelbach J, et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol. 1989;109:429-440.
95. Pierce GF, Mustoe TA, Mustoe BW, Altrock TF, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem. 1991;45:319-326.
96. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg. 1995;21: 71-81.
97. Ataliotis P, Mercola M. Distribution and functions of platelet-derived growth factors and their receptors during embryogenesis. Int Rev Cytol. 1997;172:95-127.